Copyright Reports & Markets. All rights reserved.

Global Klebsiella Pneumoniae Infection Drug Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Klebsiella Pneumoniae Infection Drug

      • 1.1 Definition of Klebsiella Pneumoniae Infection Drug
      • 1.2 Klebsiella Pneumoniae Infection Drug Segment by Type
        • 1.2.1 Global Klebsiella Pneumoniae Infection Drug Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 ATI-1503
        • 1.2.3 CA-824
        • 1.2.4 CC-1807
        • 1.2.5 Cefiderocol
        • 1.2.6 Debio-1454
        • 1.2.7 EBX-004
        • 1.2.8 Others
      • 1.3 Klebsiella Pneumoniae Infection Drug Segment by Applications
        • 1.3.1 Global Klebsiella Pneumoniae Infection Drug Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Hospital
        • 1.3.3 Clinic
        • 1.3.4 Others
      • 1.4 Global Klebsiella Pneumoniae Infection Drug Overall Market
        • 1.4.1 Global Klebsiella Pneumoniae Infection Drug Revenue (2014-2025)
        • 1.4.2 Global Klebsiella Pneumoniae Infection Drug Production (2014-2025)
        • 1.4.3 North America Klebsiella Pneumoniae Infection Drug Status and Prospect (2014-2025)
        • 1.4.4 Europe Klebsiella Pneumoniae Infection Drug Status and Prospect (2014-2025)
        • 1.4.5 China Klebsiella Pneumoniae Infection Drug Status and Prospect (2014-2025)
        • 1.4.6 Japan Klebsiella Pneumoniae Infection Drug Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Klebsiella Pneumoniae Infection Drug Status and Prospect (2014-2025)
        • 1.4.8 India Klebsiella Pneumoniae Infection Drug Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Klebsiella Pneumoniae Infection Drug
      • 2.3 Manufacturing Process Analysis of Klebsiella Pneumoniae Infection Drug
      • 2.4 Industry Chain Structure of Klebsiella Pneumoniae Infection Drug

      3 Development and Manufacturing Plants Analysis of Klebsiella Pneumoniae Infection Drug

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Klebsiella Pneumoniae Infection Drug Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Klebsiella Pneumoniae Infection Drug
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Klebsiella Pneumoniae Infection Drug Production and Capacity Analysis
      • 4.2 Klebsiella Pneumoniae Infection Drug Revenue Analysis
      • 4.3 Klebsiella Pneumoniae Infection Drug Price Analysis
      • 4.4 Market Concentration Degree

      5 Klebsiella Pneumoniae Infection Drug Regional Market Analysis

      • 5.1 Klebsiella Pneumoniae Infection Drug Production by Regions
        • 5.1.1 Global Klebsiella Pneumoniae Infection Drug Production by Regions
        • 5.1.2 Global Klebsiella Pneumoniae Infection Drug Revenue by Regions
      • 5.2 Klebsiella Pneumoniae Infection Drug Consumption by Regions
      • 5.3 North America Klebsiella Pneumoniae Infection Drug Market Analysis
        • 5.3.1 North America Klebsiella Pneumoniae Infection Drug Production
        • 5.3.2 North America Klebsiella Pneumoniae Infection Drug Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Klebsiella Pneumoniae Infection Drug Import and Export
      • 5.4 Europe Klebsiella Pneumoniae Infection Drug Market Analysis
        • 5.4.1 Europe Klebsiella Pneumoniae Infection Drug Production
        • 5.4.2 Europe Klebsiella Pneumoniae Infection Drug Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Klebsiella Pneumoniae Infection Drug Import and Export
      • 5.5 China Klebsiella Pneumoniae Infection Drug Market Analysis
        • 5.5.1 China Klebsiella Pneumoniae Infection Drug Production
        • 5.5.2 China Klebsiella Pneumoniae Infection Drug Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Klebsiella Pneumoniae Infection Drug Import and Export
      • 5.6 Japan Klebsiella Pneumoniae Infection Drug Market Analysis
        • 5.6.1 Japan Klebsiella Pneumoniae Infection Drug Production
        • 5.6.2 Japan Klebsiella Pneumoniae Infection Drug Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Klebsiella Pneumoniae Infection Drug Import and Export
      • 5.7 Southeast Asia Klebsiella Pneumoniae Infection Drug Market Analysis
        • 5.7.1 Southeast Asia Klebsiella Pneumoniae Infection Drug Production
        • 5.7.2 Southeast Asia Klebsiella Pneumoniae Infection Drug Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Klebsiella Pneumoniae Infection Drug Import and Export
      • 5.8 India Klebsiella Pneumoniae Infection Drug Market Analysis
        • 5.8.1 India Klebsiella Pneumoniae Infection Drug Production
        • 5.8.2 India Klebsiella Pneumoniae Infection Drug Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Klebsiella Pneumoniae Infection Drug Import and Export

      6 Klebsiella Pneumoniae Infection Drug Segment Market Analysis (by Type)

      • 6.1 Global Klebsiella Pneumoniae Infection Drug Production by Type
      • 6.2 Global Klebsiella Pneumoniae Infection Drug Revenue by Type
      • 6.3 Klebsiella Pneumoniae Infection Drug Price by Type

      7 Klebsiella Pneumoniae Infection Drug Segment Market Analysis (by Application)

      • 7.1 Global Klebsiella Pneumoniae Infection Drug Consumption by Application
      • 7.2 Global Klebsiella Pneumoniae Infection Drug Consumption Market Share by Application (2014-2019)

      8 Klebsiella Pneumoniae Infection Drug Major Manufacturers Analysis

      • 8.1 Acies Bio doo
        • 8.1.1 Acies Bio doo Klebsiella Pneumoniae Infection Drug Production Sites and Area Served
        • 8.1.2 Acies Bio doo Product Introduction, Application and Specification
        • 8.1.3 Acies Bio doo Klebsiella Pneumoniae Infection Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Appili Therapeutics
        • 8.2.1 Appili Therapeutics Klebsiella Pneumoniae Infection Drug Production Sites and Area Served
        • 8.2.2 Appili Therapeutics Product Introduction, Application and Specification
        • 8.2.3 Appili Therapeutics Klebsiella Pneumoniae Infection Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Debiopharm International SA
        • 8.3.1 Debiopharm International SA Klebsiella Pneumoniae Infection Drug Production Sites and Area Served
        • 8.3.2 Debiopharm International SA Product Introduction, Application and Specification
        • 8.3.3 Debiopharm International SA Klebsiella Pneumoniae Infection Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Evaxion Biotech ApS
        • 8.4.1 Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Production Sites and Area Served
        • 8.4.2 Evaxion Biotech ApS Product Introduction, Application and Specification
        • 8.4.3 Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 F. Hoffmann-La Roche Ltd
        • 8.5.1 F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Production Sites and Area Served
        • 8.5.2 F. Hoffmann-La Roche Ltd Product Introduction, Application and Specification
        • 8.5.3 F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 FOB Synthesis Inc
        • 8.6.1 FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Production Sites and Area Served
        • 8.6.2 FOB Synthesis Inc Product Introduction, Application and Specification
        • 8.6.3 FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 ImmunoClin Corp
        • 8.7.1 ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Production Sites and Area Served
        • 8.7.2 ImmunoClin Corp Product Introduction, Application and Specification
        • 8.7.3 ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Innovation Pharmaceuticals Inc
        • 8.8.1 Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Production Sites and Area Served
        • 8.8.2 Innovation Pharmaceuticals Inc Product Introduction, Application and Specification
        • 8.8.3 Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Kyorin Pharmaceutical Co Ltd
        • 8.9.1 Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Production Sites and Area Served
        • 8.9.2 Kyorin Pharmaceutical Co Ltd Product Introduction, Application and Specification
        • 8.9.3 Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Melinta Therapeutics Inc
        • 8.10.1 Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Production Sites and Area Served
        • 8.10.2 Melinta Therapeutics Inc Product Introduction, Application and Specification
        • 8.10.3 Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 Nosopharm SAS
      • 8.12 Peptilogics Inc
      • 8.13 Pfizer Inc
      • 8.14 Phico Therapeutics Ltd
      • 8.15 Sarepta Therapeutics Inc
      • 8.16 Shionogi & Co Ltd
      • 8.17 Syntiron LLC
      • 8.18 Tetraphase Pharmaceuticals Inc

      9 Development Trend of Analysis of Klebsiella Pneumoniae Infection Drug Market

      • 9.1 Global Klebsiella Pneumoniae Infection Drug Market Trend Analysis
        • 9.1.1 Global Klebsiella Pneumoniae Infection Drug Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Klebsiella Pneumoniae Infection Drug Regional Market Trend
        • 9.2.1 North America Klebsiella Pneumoniae Infection Drug Forecast 2019-2025
        • 9.2.2 Europe Klebsiella Pneumoniae Infection Drug Forecast 2019-2025
        • 9.2.3 China Klebsiella Pneumoniae Infection Drug Forecast 2019-2025
        • 9.2.4 Japan Klebsiella Pneumoniae Infection Drug Forecast 2019-2025
        • 9.2.5 Southeast Asia Klebsiella Pneumoniae Infection Drug Forecast 2019-2025
        • 9.2.6 India Klebsiella Pneumoniae Infection Drug Forecast 2019-2025
      • 9.3 Klebsiella Pneumoniae Infection Drug Market Trend (Product Type)
      • 9.4 Klebsiella Pneumoniae Infection Drug Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Klebsiella Pneumoniae Infection Drug Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global Klebsiella Pneumoniae Infection Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report focuses on Klebsiella Pneumoniae Infection Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Klebsiella Pneumoniae Infection Drug market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Klebsiella Pneumoniae Infection Drug in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Klebsiella Pneumoniae Infection Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Acies Bio doo
        Appili Therapeutics
        Debiopharm International SA
        Evaxion Biotech ApS
        F. Hoffmann-La Roche Ltd
        FOB Synthesis Inc
        ImmunoClin Corp
        Innovation Pharmaceuticals Inc
        Kyorin Pharmaceutical Co Ltd
        Melinta Therapeutics Inc
        Nosopharm SAS
        Peptilogics Inc
        Pfizer Inc
        Phico Therapeutics Ltd
        Sarepta Therapeutics Inc
        Shionogi & Co Ltd
        Syntiron LLC
        Tetraphase Pharmaceuticals Inc

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        ATI-1503
        CA-824
        CC-1807
        Cefiderocol
        Debio-1454
        EBX-004
        Others

        Segment by Application
        Hospital
        Clinic
        Others

        Buy now